US2022221461A1PendingUtilityA1
Specimen measurement system and specimen measurement method
Est. expirySep 26, 2038(~12.2 yrs left)· nominal 20-yr term from priority
G01N 33/57505G06V 20/69G06T 2207/30024G06T 7/0012G01N 1/2813G01N 15/1459G01N 33/49G01N 21/6428G01N 15/14G01N 35/0092G01N 35/00584G01N 35/02G01N 33/5094G01N 33/50G01N 2021/6439G01N 2015/1006G01N 33/57426
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a specimen measurement system including: a specimen measuring device that measures a specimen; a determination unit that determines whether or not the specimen is to be measured by a flow cytometer, based on a measurement result of the specimen measuring device.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A specimen measurement system comprising:
a specimen measuring device configured to measure a specimen for a first measurement item; a flow cytometer configured to measure the specimen treated with a labeling reagent containing an antibody for a second measurement item which is different from the first measurement item; and a determination unit configured to determine whether or not the specimen will be measured by the flow cytometer based on a measurement result of the first measurement item measured by the specimen measuring device.
2 . The specimen measurement system according to claim 1 , wherein the flow cytometer is configured to measure the specimen after being treated with the labeling reagent.
3 . The specimen measurement system according to claim 1 , wherein:
(i) the flow cytometer configured to measure a concentration of CD7, CD11b, CD13, CD14, CD15, CD16, CD33, CD34, CD45, CD56, CD117 and/or HLA-DR positive cells in the specimen; (ii) a concentration of CD5, CD10, CD19, CD20, CD45, Igκ, Igλ, CD2, CD3, CD4, CD7, CD8 and/or CD56 positive cells in the specimen; (iii) whether each of CD3, CD4, CD8, and CD45 in the specimen is positive or negative; (iv) whether each of CD55 and CD59 in the specimen is positive or negative; or (v) whether each of CD36, CD41/61, CD42bc/a/d, CD49b/29 and CD110 in the specimen is positive or negative.
4 . The specimen measurement system according to claim 1 , wherein, when the measurement result of the specimen meets a predetermined condition, the determination unit determines that the specimen is to be measured by the flow cytometer.
5 . The specimen measurement system according to claim 1 , wherein the specimen measuring device includes a flow cytometer separate from the flow cytometer.
6 . The specimen measurement system according to claim 5 , wherein the specimen measuring device measures the specimen which is not treated with a labeling reagent containing an antibody.
7 . The specimen measurement system according to claim 1 , wherein
the specimen is a blood specimen, the specimen measuring device includes a blood cell measuring apparatus that measures blood cells contained in the blood specimen, and the determination unit determines whether or not the blood specimen is to be measured by the flow cytometer, based on a measurement result of the blood cell measuring apparatus.
8 . The specimen measurement system according to claim 7 , wherein
the determination unit determines that the blood specimen is to be measured by the flow cytometer when the measurement result of the blood cell measuring apparatus indicates at least one of: blasts are present, a lymphocyte count meets a predetermined criterion, erythrocyte count meets a predetermined criterion, and platelet count meets a predetermined criterion.
9 . The specimen measurement system according to claim 7 , further comprising an image analysis apparatus configured to analyze an image of a smear of the blood specimen, wherein
the determination unit determines whether or not the blood specimen is to be measured by the flow cytometer, further based on an analysis result of the image analysis apparatus.
10 . The specimen measurement system according to claim 1 , wherein
the specimen is a blood specimen, the specimen measuring device includes an image analysis apparatus configured to analyze an image of a smear of the blood specimen, and the determination unit determines whether or not the blood specimen is to be measured by the flow cytometer, based on an analysis result of the image analysis apparatus.
11 . The specimen measurement system according to claim 9 , wherein the image analysis apparatus analyzes whether the image of the smear includes leukemia cells, and
the determination unit determines that the blood specimen is to be measured by the flow cytometer when the analysis result of the image analysis apparatus indicates that the image of the smear includes the leukemia cells.
12 . The specimen measurement system according to claim 1 , further comprising a measurement order generating unit configured to generate a measurement order for the flow cytometer, based on a measurement result of the specimen measuring device.
13 . The specimen measurement system according to claim 12 , wherein the measurement order generating unit designates the labeling reagent in the measurement order.
14 . The specimen measurement system according to claim 12 , further comprising a sample preparation device configured to prepare a sample to be measured by the flow cytometer, at least from the labeling reagent and the specimen, based on the measurement result of the first measurement item by the specimen measuring device.
15 . The specimen measurement system according to claim 14 , further comprising a specimen transport device configured to transport the specimen to the sample preparation device when the determination unit determines that the specimen is to be measured by the flow cytometer based on the measurement result of the first measurement item by the specimen measuring device.
16 . The specimen measurement system according to claim 15 , wherein the specimen transport device transports a specimen container containing the specimen.
17 . The specimen measurement system according to claim 15 , further comprising a sample transport device configured to transport the sample prepared by the sample preparation device to the flow cytometer.
18 . A specimen measurement method, comprising:
measuring a specimen by a specimen measuring device for a first measurement item; determining, by a determination unit, whether or not the specimen treated with a labeling reagent containing an antibody is to be measured by a flow cytometer, based on a measurement result of the first measurement item by the specimen measuring device; and in response to a determination result by the determination unit, measuring the specimen by the flow cytometer for a second measurement item which is different from the first measurement item.
19 . The specimen measurement system according to claim 1 , wherein the measuring the specimen by the flow cytometer is measuring the specimen after being treated with a labeling reagent containing an antibody.
20 . The specimen measurement system according to claim 1 , wherein:
(i) the second measurement item is CD7, CD11b, CD13, CD14, CD15, CD16, CD33, CD34, CD45, CD56, CD117 and/or HLA-DR positive cells in the specimen; (ii) CD5, CD10, CD19, CD20, CD45, Igκ, Igλ, CD2, CD3, CD4, CD7, CD8 and/or CD56 positive cells in the specimen; (iii) whether each of CD3, CD4, CD8, and CD45 in the specimen is positive or negative; (iv) whether each of CD55 and CD59 in the specimen is positive or negative; or (v) whether each of CD36, CD41/61, CD42bc/a/d, CD49b/29 and CD110 in the specimen is positive or negative.Join the waitlist — get patent alerts
Track US2022221461A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.